Bluejay Diagnostics, Inc.
BJDX
$4.03
$0.000.00%
| Weiss Ratings | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E | |||
| Reward Grade | E | |||
| Rating Factors | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.02 | |||
| Price History | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 11.63% | |||
| 30-Day Total Return | 1.77% | |||
| 60-Day Total Return | -1.71% | |||
| 90-Day Total Return | -18.42% | |||
| Year to Date Total Return | -12.01% | |||
| 1-Year Total Return | -98.77% | |||
| 2-Year Total Return | -99.91% | |||
| 3-Year Total Return | -99.95% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -98.89% | |||
| 52-Week Low % Change | 33.00% | |||
| Price | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $363.16 | |||
| 52-Week Low Price | $3.03 | |||
| 52-Week Low Price (Date) | Nov 19, 2024 | |||
| 52-Week High Price (Date) | Mar 12, 2024 | |||
| Valuation | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.17M | |||
| Enterprise Value | -3.33M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -7.75 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.20 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $4.03 | |||
| Enterprise Value/EBITDA (TTM) | 0.42 | |||
| Enterprise Value/EBIT | 0.41 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 191.10K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 844 327 7078 | |||
| Address | 360 Massachusetts Avenue Acton, MA 01720 | |||
| Website | bluejaydx.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -60.78% | |||
| Return on Equity | -- | |||
| Income Statement | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -7.99M | |||
| EBIT (TTM) | -8.07M | |||
| Net Income (TTM) | -8.59M | |||
| Net Income Avl. to Common (TTM) | -8.59M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 35.51% | |||
| EPS Diluted (TTM) | -7.75 | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.76M | |||
| Cash Per Share (Q) | $30.12 | |||
| Total Current Assets (Q) | 6.57M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 7.16M | |||
| Current Ratio (Q) | 6.260 | |||
| Book Value Per Share (Q) | $20.09 | |||
| Total Assets (Q) | 8.35M | |||
| Total Current Liabilities (Q) | 1.05M | |||
| Total Debt (Q) | 256.00K | |||
| Total Liabilities (Q) | 1.19M | |||
| Total Common Equity (Q) | 7.16M | |||
| Cash Flow | BJDX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -393.50K | |||
| Cash from Financing (TTM) | 9.93M | |||
| Net Change in Cash (TTM) | 678.80K | |||
| Levered Free Cash Flow (TTM) | -6.78M | |||
| Cash from Operations (TTM) | -8.86M | |||
